[Fetal aminopterin syndrome].
Harada
M
M
Department of Social Welfare Studies, Kumamoto Gakuen University.
D000014:Abnormalities, Drug-Induced / Q000503:physiopathology; D000015:Abnormalities, Multiple / Q000139:chemically induced* / Q000503:physiopathology; D000630:Aminopterin / Q000009:adverse effects*; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced*; D005333:Fetus / Q000002:abnormalities*; D005493:Folic Acid Antagonists / Q000009:adverse effects*; D006801:Humans; D007231:Infant, Newborn; D008727:Methotrexate / Q000009:adverse effects; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011379:Prognosis; D013577:Syndrome
D005493:Folic Acid Antagonists; D000630:Aminopterin; D008727:Methotrexate